APGE SG&A Expense Growth

Apogee Therapeutics Inc · SG&A Expense Growth

APGE logo

APGE SG&A Expense Growth

Latest reported44.64%
APGE FY SG&A Growth (YoY) (0.00% → 44.64%)
High-resolution chart · PNG

APGE sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Apogee Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
44.6444%
99.3775%
735.7361%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.